WealthPLAN Partners’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Buy
19,532
+8,483
+77% +$103K 0.04% 208
2026
Q1
$154K Buy
+11,049
New +$155K 0.03% 215

Other funds holding BTAL

WealthPLAN Partners's BTAL Position: Q2 2026 in Review

WealthPLAN Partners increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 77% in Q2 2026, buying an estimated $103K and bringing the position to 19,532 shares worth $218K. The position accounts for 0.04% of the portfolio, ranked #208.

WealthPLAN Partners first reported a position in BTAL in Q1 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • WealthPLAN Partners held 19,532 shares of AGF US Market Neutral Anti-Beta Fund worth $218K as of Q2 2026.
  • WealthPLAN Partners bought 8,483 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $103K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.04% of WealthPLAN Partners's portfolio in Q2 2026, its #208 holding.
  • WealthPLAN Partners first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2026 and has held it in 2 quarters since.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on WealthPLAN Partners's 13F filing for Q2 2026, filed 28 Jul 2026.